Stay updated on Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing Revision: v3.6.5, indicating a minor version update to the page’s template or underlying platform.
    Difference
    0.1%
    Check dated 2026-09-01T19:39:22.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.5, signaling a minor update to the page. This change represents a backend or UI update rather than a modification to study details.
    Difference
    0.1%
    Check dated 2026-08-11T16:22:52.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a small backend/UI update that does not affect the study details or displayed information.
    Difference
    0.1%
    Check dated 2026-07-28T05:23:39.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the page's documentation or rendering.
    Difference
    0.1%
    Check dated 2026-07-06T18:19:05.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision tag on the page was updated from v3.6.0 to v3.6.2, indicating a platform revision. The change is purely technical and does not affect the study details displayed on the page.
    Difference
    0.1%
    Check dated 2026-06-29T15:49:41.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was standardized. The page's revision metadata was updated to Revision: v3.6.0, and additional fields such as 'Last verified' and 'Last known status was' appeared.
    Difference
    1%
    Check dated 2026-06-15T08:34:19.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.